{"metadata": {"source": "pubchem", "title": "Fentanyl | C22H28N2O | CID 3345 - PubChem", "description": "Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3345", "drug": "Fentanyl", "cid": 3345, "char_count": 196495, "word_count": 26843, "doc_id": "doc_16", "num_chunks": 282, "chunk_id": "16::chunk_94", "document_index": 16, "latency_s": 1.102420399998664, "prompt_toks": 49734, "completion_toks": 79, "relevance_score": 0.014227047}, "content": "Drug: Fentanyl | cid: 3345\nSource: pubchem | Source description: Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Actiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n200 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nOral Transmucosal Fentanyl Citrate, C-II (Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n400 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nActiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n400 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nOral Transmucosal Fentanyl Citrate, C-II (Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n600 ug (of fentanyl)\n\n\n                    Context: \n                    This excerpt details various formulations and strengths of buccal fentanyl lozenges, specifically Actiq (Cephalon), used for transmucosal administration. It provides dosage information (200-600 µg), multiple brand and manufacturer details, and highlights different strengths available, situating it within the broader context of fentanyl drug formulations and clinical use discussed in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Fentanyl | C22H28N2O | CID 3345 - PubChem", "description": "Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3345", "drug": "Fentanyl", "cid": 3345, "char_count": 196495, "word_count": 26843, "doc_id": "doc_16", "num_chunks": 282, "chunk_id": "16::chunk_96", "document_index": 16, "latency_s": 1.1449552999984007, "prompt_toks": 49731, "completion_toks": 90, "relevance_score": 0.010052369}, "content": "Drug: Fentanyl | cid: 3345\nSource: pubchem | Source description: Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Actiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n800 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nOral Transmucosal Fentanyl Citrate, C-II (Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nTransdermal System\n\nStrength\n\n1200 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nActiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n1200 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nOral Transmucosal Fentanyl Citrate, C-II (Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n1600 ug (of fentanyl)\n\n\n                    Context: \n                    This excerpt details specific dosage forms and strengths for the drug formulation Actiq, C-II (Cephalon), including buccal lozenges and transdermal systems containing fentanyl at varying strengths from 800 to 1600 micrograms. It is relevant to the comprehensive overview of fentanyl's marketed pharmaceutical preparations, providing precise information on formulations, administration routes, and manufacturer options crucial for identifying product-specific data within the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Fentanyl | C22H28N2O | CID 3345 - PubChem", "description": "Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3345", "drug": "Fentanyl", "cid": 3345, "char_count": 196495, "word_count": 26843, "doc_id": "doc_16", "num_chunks": 282, "chunk_id": "16::chunk_95", "document_index": 16, "latency_s": 1.2100122999981977, "prompt_toks": 49704, "completion_toks": 78, "relevance_score": 0.0074606435}, "content": "Drug: Fentanyl | cid: 3345\nSource: pubchem | Source description: Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Route of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n600 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nActiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n600 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nOral Transmucosal Fentanyl Citrate, C-II (Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n800 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nActiq, C-II (Cephalon)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nLozenge (solid drug matrix on a handle)\n\nStrength\n\n800 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\n\n                    Context: \n                    This excerpt details specific buccal transmission routes for fentanyl in lozenge form, including dosages of 600 and 800 micrograms, marketed under brand names such as Actiq. It is part of the full medication formulation and dosing information, providing essential data for identifying formulation types, strengths, administration routes, and manufacturers within the comprehensive chemical and pharmaceutical data on fentanyl.\n                "}
